Integrum AB (publ) (STO:INTEG.B)
8.28
+0.20 (2.48%)
Jul 24, 2026, 5:16 PM CET
Integrum AB Revenue
In the fiscal year ending April 30, 2026, Integrum AB had annual revenue of 96.14M SEK, down -1.42%. Integrum AB had revenue of 26.41M in the quarter ending April 30, 2026, a decrease of -7.18%.
Revenue
96.14M
Revenue Growth
-1.42%
P/S Ratio
2.30
Revenue / Employee
2.83M
Employees
34
Market Cap
220.81M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Apr 30, 2026 | 96.14M | -1.38M | -1.42% |
| Apr 30, 2025 | 97.52M | -18.76M | -16.13% |
| Apr 30, 2024 | 116.28M | 33.15M | 39.88% |
| Apr 30, 2023 | 83.13M | 6.45M | 8.41% |
| Apr 30, 2022 | 76.68M | 25.20M | 48.96% |
| Apr 30, 2021 | 51.48M | 21.62M | 72.42% |
| Apr 30, 2020 | 29.86M | 1.67M | 5.93% |
| Apr 30, 2019 | 28.18M | 7.72M | 37.72% |
| Apr 30, 2018 | 20.46M | -3.03M | -12.88% |
| Apr 30, 2017 | 23.49M | 5.01M | 27.11% |
| Apr 30, 2016 | 18.48M | 1.20M | 6.96% |
| Apr 30, 2015 | 17.28M | -1.72M | -9.06% |
| Apr 30, 2014 | 19.00M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Boule Diagnostics AB | 461.29M |
| Arcoma AB | 127.06M |
| Promimic AB | 49.86M |
| SciBase Holding AB | 45.88M |
| BrainCool AB | 44.02M |
| Ortoma AB | 42.65M |
| Nosa Plugs AB | 27.87M |
| Episurf Medical AB | 26.10M |
Integrum AB News
- 7 weeks ago - Integrum AB Quarterly report: Q4 2026 - Filings
- 5 months ago - Integrum AB Quarterly report: Q3 2026 - Filings
- 8 months ago - Integrum AB Transcript: Q2 25/26 - Transcripts
- 8 months ago - Integrum AB Quarterly report: Q2 2026 - Filings
- 11 months ago - Integrum AB Transcript: Q1 25/26 - Transcripts
- 11 months ago - Integrum AB Quarterly report: Q1 2026 - Filings